GLEASON SCORING OF PROSTATE BIOPSIES IN ACTIVE SURVEILLANCE PATIENTS OBTAINED BY STANDARD TRUS AND MRI: AN UPDATE

被引:1
|
作者
Bienvenu, James
Haddock, Peter
Cusano, Joseph
Wagner, Joseph
机构
来源
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词
D O I
10.1016/j.juro.2016.02.2581
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP16-16
引用
收藏
页码:E167 / E167
页数:1
相关论文
共 50 条
  • [1] COMPARATIVE ASSESSMENT OF GLEASON SCORING OF PROSTATE BIOPSIES OBTAINED BY STANDARD TRUS AND MRI-TRUS AT FOLLOW UP IN ACTIVE SURVEILLANCE PATIENTS
    Jackson, Max
    Haddock, Peter
    Staff, Ilene
    Dorin, Ryan
    Kesler, Stuart
    O'Loughlin, Michael
    Meraney, Anoop
    Wagner, Joseph
    JOURNAL OF UROLOGY, 2015, 193 (04): : E596 - E596
  • [2] Role of MRI guided targetted prostate biopsy in patients with previous negative TRUS biopsy or on Active Surveillance
    Thandapani, Karthik
    Chau, Tsang Woon
    Paulraj, Thamboo Thomas
    Edmund, Chiong
    Lim, Tan Lincoln Guan
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 340 - 340
  • [3] Multiparametric-MRI and targeted biopsies in the management of prostate cancer patients on active surveillance
    Sandler, Kiri
    Patel, Mausam
    Lynne, Charles
    Parekh, Dipen J.
    Punnen, Sanoj
    Jorda, Merce
    Casillas, Javier
    Pollack, Alan
    Stoyanova, Radka
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [4] Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies
    Wetterauer, Christian
    Federer-Gsponer, Joel R.
    Leboutte, Francois D. J. P.
    Mona, Robin
    Ebbing, Jan
    Rentsch, Cyrill A.
    Manka, Lukas
    Seifert, Hans H.
    Wyler, Stephen
    Recker, Franz
    Kwiatkowski, Maciej
    UROLOGIA INTERNATIONALIS, 2022, 106 (01) : 83 - 89
  • [5] Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naive, previous negative biopsy patients and men undergoing active surveillance
    Borghesi, Marco
    Bianchi, Lorenzo
    Barbaresi, Umberto
    Vagnoni, Valerio
    Corcioni, Beniamino
    Gaudiano, Caterina
    Fiorentino, Michelangelo
    Giunchi, Francesca
    Chessa, Francesco
    Garofalo, Marco
    Bertaccini, Alessandro
    Angelini, Stefano
    Ercolino, Amelio
    Casablanca, Carlo
    Droghetti, Matteo
    Golfieri, Rita
    Schiavina, Riccardo
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (03): : 357 - 366
  • [6] Changes in Gleason score grading on serial follow-up biopsies in prostate cancer patients undergoing active surveillance
    Guijarro, A.
    Hernandez, V.
    Lopez, B.
    Capitan, C.
    Perez-Fernandez, E.
    de la Pena, E.
    de la Morena, J. M.
    Llorente, C.
    ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (03): : 139 - 143
  • [7] COMPARISON OF MRI/FUSION VERSUS TRUS CONFIRMATORY BIOPSY IN ACTIVE SURVEILLANCE PATIENTS
    Feng, David
    Dallmer, Jeremiah R.
    Avulova, Svetlana
    Luckenbaugh, Amy N.
    Laviana, Aaron A.
    Chang, Sam S.
    Penson, David F.
    Resnick, Matthew J.
    Scarpato, Kristen R.
    Barocas, Daniel A.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1013 - E1014
  • [8] Significance of Change in Gleason Grade in Patients on Active Surveillance for Prostate Cancer
    Marks, Leonard S.
    JOURNAL OF UROLOGY, 2015, 194 (01): : 8 - 9
  • [9] Is BMI a risk factor for active surveillance progression in patients with prostate cancer diagnosed by MRI-Trus fusion biopsy?
    Rayn, Kareem
    Gold, Samuel
    Hale, Graham R.
    Baiocco, Joey
    Bloom, Jonathan
    Valera, Vladimir
    Wood, Brad J.
    Turkbey, Baris
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] The development of a dynamic prediction model using MRI predicting Gleason upgrading on prostate biopsy in patients on active surveillance
    Nieboer, D.
    Luiting, H. B.
    Valdagni, R.
    Boeve, E. R.
    Rannikko, A.
    Semjenow, A.
    Staerman, F.
    Chiu, P. K.
    Berge, V.
    Roobol, M. J.
    EUROPEAN UROLOGY, 2021, 79 : S1448 - S1449